Sustained generic pricing pressure
Generic API business faces ongoing pricing erosion, with no improvement expected in the next two quarters, potentially impacting margins.
DIVISLAB / Q2-FY26 / risks
Keep the risk register visible.
Divi's Laboratories · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
Regulatory delays in new project validations
Commercialization of three major capex projects depends on regulatory approvals (EU, US), which could be delayed, pushing revenue contribution beyond 1-2 years.
Competition from new CDMO entrants
Analyst raised concern about increased competition in custom synthesis from Indian players; management acknowledged but emphasized long-term relationships and non-price factors.
US tariff impact on raw material costs
Management noted potential cost increases from US tariffs on Chinese suppliers and Russia sanctions, though mitigated by inventory and diversified sourcing.